Research About Meet PRIA

Support Data Sources Privacy Policy Terms of Service Your Privacy Choiceshello@policyrisk.com

© 2026 PRIA Technologies, LLC. All rights reserved.

PRIA provides educational policy intelligence and is not a source of investment, legal, or financial advice. Content is for informational purposes only.

™

Your Policy Risk Impact Agent

Research

At My Address
Federal Courts
Daily Briefings
Medicare & Social Security
Congressional Bills
Federal Register
Tariffs
Fed Decisions & The Economy
State Tracker
World Watch
U.S. Code
U.S. Constitution

Knowledge

Search Polipedia
Daily Briefings
Calculators
What is Policy Risk?
The Countdown

Company

About PRIA
Support

Get PRIA

Support Data Sources Privacy Policy Terms of Service Your Privacy Choices

hello@policyrisk.com

© 2026 PRIA Technologies, LLC. All rights reserved.

PRIA is a trademark of PRIA Technologies, LLC.

PRIA provides educational policy intelligence and is not a source of investment, legal, or financial advice. Content is for informational purposes only.

Indiana Statutes, Title 12

™

Your Policy Risk Impact Agent

Indiana/Statutes

← All Indiana coverage

Title 12, HUMAN SERVICES

328 chapters · 3,181 sections in this title.

All chapters in Title 123,181 Ch 2.1, Service Coordination Services for De…375 Ch 2, Commission on Aging229 Ch 1, Bureau of Aging Services203 Ch 5, Blind Vending Services176 Ch 3, Adult Protective Services138 Ch 4, Division Advisory Council135 Ch 6, Residential Care Assistance113 Ch 7, Adult Guardianship Services108 Ch 8, Institute for Autism105 Ch 14, Representative Payees and Bill Payers101 Ch 13, Long Term Care Ombudsman Program89 Ch 9, Reporting of Blind or Visually Impai…78 Ch 25, Voter Registration Services and Food…78 Ch 12, Managed Care77

59 sections·Filtered byTitle 12✕Ch 35✕

Ind. Code § 12-15-35-48 Board review of managed care organization prescription drug program
1.5K chars
Sec. 48. (a) The board shall review the prescription drug program of a managed care organization that participates in a risk based managed care program at least one (1) time per year. The board's review of a prescription drug program must include the following: (1) An analysis of…
Ind. Code § 12-15-35-49 Information provided by office
0.3K chars
Sec. 49. (a) The office shall provide the board with information necessary for the board to carry out its duties under this chapter. (b) The office shall provide the information required under subsection (a): (1) when requested by the board; and (2) in a timely manner. As added b…
Ind. Code § 12-15-35-5 "Criteria" defined
0.3K chars
Sec. 5. As used in this chapter, "criteria" means the predetermined and explicitly accepted elements that are used to measure drug use on an ongoing basis to determine if the use is appropriate, medically necessary, and not likely to result in adverse medical outcomes. As added b…
Ind. Code § 12-15-35-50 Maximum allowable cost schedule for drugs; pharmacy participation in Medicaid program

Showing 51–59 of 59

Page 2 of 2

← PreviousNext →

0.8K chars

Sec. 50. (a) IC 12-15-13-6 does not apply to this section. (b) The office shall maintain a website and post on the website any changes concerning the office's maximum allowable cost schedule for drugs. (c) A change in the office's maximum allowable cost schedule for drugs may not…

Ind. Code § 12-15-35-51 Advisory committee; duties; report

3.3K chars

Sec. 51. (a) As used in this section, "advisory committee" refers to the mental health Medicaid quality advisory committee established by subsection (b). (b) The mental health Medicaid quality advisory committee is established. The advisory committee consists of the following mem…

Ind. Code § 12-15-35-6 "Drug-disease contraindication" defined

0.2K chars

Sec. 6. As used in this chapter, "drug-disease contraindication" means an occurrence in which the therapeutic effect of a drug is adversely altered by the presence of another disease condition. As added by P.L.75-1992, SEC.19.

Ind. Code § 12-15-35-7 "Drug-drug interaction" defined

0.4K chars

Sec. 7. As used in this chapter, "drug-drug interaction" means an occurrence in which at least two (2) drugs taken by a recipient leads to clinically significant toxicity that: (1) is characteristic of one (1) or any of the drugs present; or (2) leads to the interference with the…

Ind. Code § 12-15-35-8 "Drug utilization review" or "DUR" defined

0.3K chars

Sec. 8. As used in this chapter, "drug utilization review" or "DUR" means the program designed to measure and assess on a retrospective and a prospective basis the proper use of outpatient drugs in the Medicaid program. As added by P.L.75-1992, SEC.19.

Ind. Code § 12-15-35-9 "Intervention" defined

0.2K chars

Sec. 9. As used in this chapter, "intervention" means an action taken by the board with a prescriber or pharmacist to inform about or to influence prescribing or dispensing practices or utilization of drugs. As added by P.L.75-1992, SEC.19.